Hunan Province Tumor Hospital
2 clinical trials · 2 recruiting · OTHER
Trials by Hunan Province Tumor Hospital
RECRUITINGNCT05991193
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical...
Sponsor: Hunan Province Tumor HospitalEnrolling: 1001 location
NSCLC
RECRUITINGPhase 2NCT05266846
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
This is an open-label, multiple centers, two-arms phase II study to evaluate the safety and efficacy Pembrolizumab,Bevacizumab in combination with Chemotherapy could improve PFS...
Sponsor: Hunan Province Tumor HospitalEnrolling: 781 location
ALK Gene MutationLung AdenocarcinomaImmunotherapy